InflaRx (IFRX) Intangibles (2016 - 2026)
InflaRx's (IFRX) quarterly Intangibles came in at $53382.5 in Q1 2026, down 6.26% year-on-year from $56944.8 in Q1 2025, and up 8.53% quarter-over-quarter from $49186.7 in Q4 2025.
InflaRx (IFRX) Intangibles (2016 - 2026) Analysis & Trends
InflaRx has disclosed Intangibles across 11 years of filings, most recently posting $53382.5 for Q1 2026.
- Intangibles for Q1 2026 came in at $53382.5, down 6.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $53382.5 (down 6.26% YoY), and the FY2025 annual result was $49186.7, down 9.36% from the prior year.
- Intangibles came in at $53382.5 for Q1 2026 at InflaRx, up from $49186.7 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $235486.7 in Q1 2022 to a low of $48136.1 in Q3 2024.
- The 5-year median for Intangibles is $56944.8 (2025), against an average of $93394.4.
- Across the five-year window, Intangibles tumbled 55.79% in 2023 and climbed 17.36% in 2025, its largest moves.
- InflaRx's Intangibles stood at $141717.5 in 2022, then tumbled by 47.75% to $74044.0 in 2023, then dropped by 26.71% to $54264.3 in 2024, then declined by 9.36% to $49186.7 in 2025, then climbed by 8.53% to $53382.5 in 2026.
- The last three Intangibles figures came in at $53382.5 (Q1 2026), $49186.7 (Q4 2025), and $53988.1 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 7.73 Mn |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 | 53,382.49 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53,382.49 |
| Dec 31, 2025 | 49,186.66 |
| Sep 30, 2025 | 53,988.13 |
| Jun 30, 2025 | 56,717.97 |
| Mar 31, 2025 | 56,944.82 |
| Dec 31, 2024 | 54,264.34 |
| Sep 30, 2024 | 48,136.06 |
| Jun 30, 2024 | 48,326.41 |
| Mar 31, 2024 | 56,648.33 |
| Dec 31, 2023 | 74,044.03 |
| Sep 30, 2023 | 72,646.00 |
| Jun 30, 2023 | 98,862.36 |
| Mar 31, 2023 | 123,270.09 |
| Dec 31, 2022 | 141,717.46 |
| Sep 30, 2022 | 164,311.41 |
| Jun 30, 2022 | 199,772.22 |
| Mar 31, 2022 | 235,486.66 |
| Dec 31, 2021 | 269,080.27 |
| Sep 30, 2021 | 309,729.20 |
| Jun 30, 2021 | 351,609.93 |